Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

New York Times (NYT) Financials

New York Times logo
$75.27 -1.41 (-1.84%)
Closing price 05/19/2026 03:59 PM Eastern
Extended Trading
$75.14 -0.13 (-0.17%)
As of 05/19/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for New York Times

Annual Income Statements for New York Times

This table shows New York Times' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
63 29 4.30 126 140 100 220 174 232 294 344
Consolidated Net Income / (Loss)
63 24 6.84 127 140 101 220 174 233 294 344
Net Income / (Loss) Continuing Operations
63 26 7.27 127 140 101 220 174 233 294 344
Total Pre-Tax Income
97 31 111 176 164 115 291 236 303 383 451
Total Operating Income
137 113 177 190 176 176 268 202 276 351 432
Total Gross Profit
961 926 1,413 796 824 824 1,035 1,099 1,177 1,276 1,435
Total Revenue
1,579 1,555 1,666 1,744 1,812 1,784 2,075 2,308 2,426 2,586 2,825
Operating Revenue
1,490 1,555 1,666 1,744 1,812 1,784 2,075 2,308 2,426 2,586 2,825
Total Cost of Revenue
618 629 253 948 988 959 1,040 1,209 1,249 1,310 1,390
Operating Cost of Revenue
618 629 253 948 988 959 1,040 1,209 1,249 1,310 1,390
Total Operating Expenses
825 813 1,236 606 648 648 767 897 901 925 1,004
Selling, General & Admin Expense
714 728 815 197 207 224 250 289 311 308 328
Marketing Expense
- - - 271 273 229 295 268 260 278 307
Research & Development Expense
- - - 84 106 133 161 204 229 248 264
Depreciation Expense
62 62 62 59 61 62 58 83 86 83 85
Other Operating Expenses / (Income)
49 6.73 359 -4.85 -2.05 0.00 0.00 15 -0.61 -2.98 2.97
Impairment Charge
- - - - - 0.00 0.00 4.07 15 0.00 2.86
Other Special Charges / (Income)
0.00 - - - 0.00 0.00 3.83 0.00 0.00 11 13
Total Other Income / (Expense), net
-40 -82 -65 -14 -11 -61 22 34 26 32 20
Interest & Investment Income
-0.78 -36 19 11 0.00 5.00 0.00 41 24 36 38
Other Income / (Expense), net
- -11 -64 -8.27 -7.30 -89 -10 -6.66 2.74 -4.16 -19
Income Tax Expense
34 4.42 104 49 24 15 71 62 70 90 107
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.40 -5.24 2.54 1.78 0.00 0.73 0.00 0.00 0.37 0.00 0.00
Basic Earnings per Share
$0.38 $0.18 $0.03 $0.76 $0.84 $0.60 $1.31 $1.04 $1.41 $1.79 $2.11
Weighted Average Basic Shares Outstanding
164.39M 161.13M 161.93M 164.85M 166.04M 166.97M 167.93M 166.87M 164.72M 164.43M 163.16M
Diluted Earnings per Share
$0.38 $0.18 $0.03 $0.75 $0.83 $0.60 $1.31 $1.04 $1.40 $1.77 $2.09
Weighted Average Diluted Shares Outstanding
166.42M 162.82M 164.26M 166.94M 167.55M 168.04M 168.53M 167.14M 165.66M 165.80M 164.94M
Weighted Average Basic & Diluted Shares Outstanding
166.40M 161.50M 143.20M 165.40M 166.40M 167.44M 167.53M 164.47M 164.10M 163.30M 161.24M
Cash Dividends to Common per Share
$0.16 $0.16 $0.16 $0.16 $0.20 $0.24 $0.28 $0.36 $0.44 $0.52 $0.72

Quarterly Income Statements for New York Times

This table shows New York Times' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
54 110 40 66 64 124 50 83 82 130 88
Consolidated Net Income / (Loss)
54 110 40 66 64 124 50 83 82 130 88
Net Income / (Loss) Continuing Operations
54 110 40 66 64 124 50 83 82 130 88
Total Pre-Tax Income
70 140 56 87 85 156 64 112 108 168 98
Total Operating Income
64 129 48 79 77 147 59 107 105 162 91
Total Gross Profit
287 355 277 302 308 389 301 347 352 435 349
Total Revenue
598 676 594 625 640 727 636 686 701 802 712
Operating Revenue
598 676 594 625 640 727 636 686 701 802 712
Total Cost of Revenue
311 321 317 323 332 338 335 339 349 367 363
Operating Cost of Revenue
311 321 317 323 332 338 335 339 349 367 363
Total Operating Expenses
224 226 229 223 232 242 243 241 247 274 259
Selling, General & Admin Expense
82 76 79 77 76 76 80 83 77 89 86
Marketing Expense
63 68 65 61 69 83 66 69 80 92 77
Research & Development Expense
57 58 63 62 61 62 67 64 67 67 70
Depreciation Expense
21 22 21 21 21 21 21 21 21 21 21
Other Operating Expenses / (Income)
-2.27 - 0.00 0.00 0.00 - 4.45 0.00 0.00 -1.49 0.00
Other Special Charges / (Income)
0.00 - 0.99 1.98 4.62 3.21 4.40 3.49 2.41 3.02 4.21
Total Other Income / (Expense), net
6.42 11 7.34 7.67 8.32 9.00 5.33 5.11 3.21 6.04 7.70
Interest & Investment Income
5.74 - 8.39 8.70 9.37 - 9.97 9.75 7.85 11 11
Other Income / (Expense), net
0.68 0.68 -1.05 -1.02 -1.05 -1.03 -4.64 -4.64 -4.64 -4.64 -3.58
Income Tax Expense
16 30 15 22 21 32 14 29 26 38 10
Basic Earnings per Share
$0.33 $0.66 $0.25 $0.40 $0.39 $0.75 $0.30 $0.51 $0.50 $0.80 $0.54
Weighted Average Basic Shares Outstanding
164.57M 164.72M 164.63M 164.54M 164.42M 164.43M 163.78M 163.33M 163.02M 163.16M 162.04M
Diluted Earnings per Share
$0.32 $0.67 $0.24 $0.40 $0.39 $0.74 $0.30 $0.50 $0.50 $0.79 $0.54
Weighted Average Diluted Shares Outstanding
165.41M 165.66M 165.63M 165.51M 165.85M 165.80M 164.91M 164.35M 164.40M 164.94M 163.70M
Weighted Average Basic & Diluted Shares Outstanding
164.41M 164.10M 164.31M 164.23M 163.95M 163.30M 163.05M 162.82M 162.35M 161.24M 161.86M
Cash Dividends to Common per Share
$0.11 $0.11 $0.13 $0.13 $0.13 $0.13 $0.18 $0.18 $0.18 $0.18 $0.23

Annual Cash Flow Statements for New York Times

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-70 -8.68 75 60 -12 54 33 -97 68 -88 57
Net Cash From Operating Activities
179 104 87 157 190 298 269 151 361 411 584
Net Cash From Continuing Operating Activities
179 104 87 157 190 298 269 151 361 411 584
Net Income / (Loss) Continuing Operations
63 24 6.84 127 140 101 220 174 233 294 344
Consolidated Net Income / (Loss)
63 24 6.84 127 140 101 220 174 233 294 344
Depreciation Expense
62 62 62 59 61 62 58 83 86 83 85
Amortization Expense
- - - 0.00 7.38 8.57 9.49 9.92 9.23 9.09 10
Non-Cash Adjustments To Reconcile Net Income
58 48 -78 -35 -15 79 -20 0.76 36 38 90
Changes in Operating Assets and Liabilities, net
-3.84 -29 96 5.52 -2.80 47 2.35 -117 -3.24 -13 56
Net Cash From Investing Activities
-31 124 14 -101 93 -199 -181 -74 -160 -306 -221
Net Cash From Continuing Investing Activities
-31 124 14 -101 93 -199 -181 -74 -160 -306 -221
Purchase of Property, Plant & Equipment
-27 -30 -85 -77 -45 -34 -35 -37 -23 -29 -34
Purchase of Investments
-824 -569 -467 -470 -572 -632 -763 -6.65 -286 -480 -653
Sale and/or Maturity of Investments
818 725 564 446 708 498 614 483 145 191 453
Other Investing Activities, net
1.93 38 1.32 0.43 3.27 2.85 3.72 2.48 4.75 13 13
Net Cash From Financing Activities
-218 -237 -26 3.82 -295 -45 -55 -174 -133 -193 -306
Net Cash From Continuing Financing Activities
-218 -237 -26 3.82 -295 -45 -55 -174 -133 -193 -306
Repurchase of Common Equity
-69 -16 - - - 0.00 0.00 -105 -45 -85 -165
Payment of Dividends
-27 -26 -26 -26 -32 -38 -45 -57 -70 -83 -110
Other Financing Activities, net
-1.45 -6.44 0.54 31 -11 -6.54 -9.61 -12 -18 -25 -30
Cash Interest Paid
41 0.04 28 28 28 0.51 0.55 1.58 0.71 0.72 0.11
Cash Income Taxes Paid
21 0.05 22 -1.07 30 24 66 110 72 113 72

Quarterly Cash Flow Statements for New York Times

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-9.60 53 -82 17 -18 -5.01 -17 15 52 6.54 -70
Net Cash From Operating Activities
104 137 53 80 126 152 99 114 208 164 92
Net Cash From Continuing Operating Activities
104 137 53 80 126 152 99 114 211 160 92
Net Income / (Loss) Continuing Operations
54 110 40 66 64 124 50 83 82 130 88
Consolidated Net Income / (Loss)
54 110 40 66 64 124 50 83 82 130 88
Depreciation Expense
21 22 21 21 21 21 21 21 21 21 21
Amortization Expense
2.20 2.05 2.22 2.24 2.31 2.32 2.33 2.34 - - 2.76
Non-Cash Adjustments To Reconcile Net Income
7.90 22 16 13 8.96 20 19 12 23 29 24
Changes in Operating Assets and Liabilities, net
19 -19 -26 -21 29 -16 6.50 -4.56 90 -29 -43
Net Cash From Investing Activities
-92 -62 -66 -30 -101 -109 -8.34 -44 -97 -72 -23
Net Cash From Continuing Investing Activities
-92 -62 -66 -30 -101 -109 -8.34 -44 -97 -72 -23
Purchase of Property, Plant & Equipment
-5.75 -6.13 -6.42 -7.63 -7.06 -8.06 -9.24 -10 -7.88 -6.53 -11
Purchase of Investments
-142 -100 -113 -72 -152 -143 -168 -132 -173 -179 -129
Sale and/or Maturity of Investments
53 44 52 49 58 31 162 98 78 114 117
Other Investing Activities, net
2.45 - 0.55 0.81 -0.06 11 7.23 0.32 5.48 -0.21 0.56
Net Cash From Financing Activities
-22 -21 -69 -34 -42 -48 -107 -54 -59 -85 -139
Net Cash From Continuing Financing Activities
-22 -21 -69 -34 -42 -48 -107 -54 -59 -85 -139
Repurchase of Common Equity
- -0.96 -32 -9.55 -18 -25 -59 -24 -27 -55 -56
Payment of Dividends
-18 -18 -19 -21 -21 -21 -22 -30 -29 -29 -30
Other Financing Activities, net
-3.49 -1.47 -18 -2.70 -2.49 -2.02 -26 -1.28 -2.25 -0.66 -52

Annual Balance Sheets for New York Times

This table presents New York Times' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,418 2,185 2,100 2,197 2,089 2,308 2,564 2,534 2,715 2,841 2,997
Total Current Assets
863 796 750 894 717 836 953 656 782 936 1,028
Cash & Equivalents
106 101 183 242 230 286 320 221 289 199 255
Short-Term Investments
508 450 309 371 202 309 341 126 162 366 387
Accounts Receivable
207 197 185 222 213 184 233 218 242 250 291
Prepaid Expenses
19 16 23 25 29 29 33 55 60 50 60
Other Current Assets
23 33 50 33 42 27 26 36 28 71 35
Plant, Property, & Equipment, net
632 597 641 639 627 595 575 554 514 489 462
Total Noncurrent Assets
923 792 709 664 745 877 2,964 1,324 1,419 1,416 1,507
Long-Term Investments
314 203 241 214 252 287 413 139 258 346 526
Goodwill
109 135 144 140 139 172 166 414 416 412 409
Intangible Assets
- - - - - - 14 317 285 258 229
Noncurrent Deferred & Refundable Income Taxes
309 301 153 128 115 100 96 96 115 111 73
Other Noncurrent Operating Assets
191 154 171 182 240 319 2,187 288 262 218 270
Total Liabilities & Shareholders' Equity
2,418 2,185 2,100 2,197 2,089 2,308 2,564 2,534 2,715 2,841 2,997
Total Liabilities
1,589 1,341 1,202 1,154 915 980 1,023 934 951 914 956
Total Current Liabilities
564 399 416 673 438 487 559 571 612 614 667
Accounts Payable
96 104 125 112 117 123 127 115 117 124 136
Accrued Expenses
121 131 111 120 124 137 146 136 148 125 137
Current Employee Benefit Liabilities
98 96 105 105 109 121 166 165 174 178 186
Other Current Liabilities
- - 75 84 88 105 119 156 173 187 208
Total Noncurrent Liabilities
1,026 942 787 481 478 493 464 363 340 301 289
Noncurrent Employee Benefit Liabilities
691 617 454 403 351 365 331 252 239 215 211
Other Noncurrent Operating Liabilities
92 79 82 78 126 128 133 111 101 86 78
Total Equity & Noncontrolling Interests
828 844 897 1,043 1,174 1,328 1,541 1,600 1,763 1,927 2,041
Total Preferred & Common Equity
827 848 897 1,041 1,172 1,326 1,539 1,598 1,763 1,927 2,041
Total Common Equity
827 848 897 1,041 1,172 1,326 1,539 1,598 1,763 1,927 2,041
Common Stock
163 167 181 224 226 234 248 273 319 374 430
Retained Earnings
1,329 1,332 1,310 1,506 1,613 1,673 1,845 1,959 2,118 2,325 2,551
Treasury Stock
-156 -171 -171 -171 -171 -171 - -276 -321 -406 -573
Accumulated Other Comprehensive Income / (Loss)
-509 -480 -423 -518 -495 -410 -383 -358 -353 -366 -366

Quarterly Balance Sheets for New York Times

This table presents New York Times' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/25/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
2,515 2,472 2,479 2,547 2,623 2,673 2,762 2,735 2,805 2,887 2,859
Total Current Assets
543 634 675 658 681 716 795 802 855 938 927
Cash & Equivalents
190 235 246 236 207 223 205 183 198 249 187
Short-Term Investments
103 139 171 163 172 188 288 339 342 368 408
Accounts Receivable
164 166 159 164 178 181 189 193 211 204 235
Prepaid Expenses
59 58 61 57 59 50 45 50 58 53 59
Other Current Assets
28 35 38 39 65 73 68 37 46 64 39
Plant, Property, & Equipment, net
561 546 531 524 508 503 495 483 478 471 460
Total Noncurrent Assets
1,411 1,292 1,273 1,365 1,434 1,454 1,472 1,451 1,472 1,478 1,472
Long-Term Investments
176 100 94 189 307 313 327 380 411 479 513
Goodwill
406 415 415 413 415 414 417 415 409 409 408
Intangible Assets
329 310 303 293 278 272 265 251 243 236 222
Noncurrent Deferred & Refundable Income Taxes
112 106 116 116 121 128 131 123 128 73 62
Other Noncurrent Operating Assets
388 361 346 353 313 328 332 281 280 280 268
Total Liabilities & Shareholders' Equity
2,515 2,472 2,479 2,547 2,623 2,673 2,762 2,735 2,805 2,887 2,859
Total Liabilities
973 895 872 891 875 868 910 850 869 907 858
Total Current Liabilities
556 540 532 554 545 543 590 555 578 615 578
Accounts Payable
120 122 111 120 121 121 137 122 120 131 138
Accrued Expenses
139 155 125 140 157 123 129 144 134 124 123
Current Employee Benefit Liabilities
145 100 139 138 89 124 146 96 133 162 101
Other Current Liabilities
152 164 157 157 178 175 177 194 190 198 216
Total Noncurrent Liabilities
417 355 340 337 330 325 320 295 291 291 280
Noncurrent Employee Benefit Liabilities
304 249 246 240 236 233 230 215 212 209 207
Other Noncurrent Operating Liabilities
113 106 93 97 94 92 90 80 79 83 73
Total Equity & Noncontrolling Interests
1,542 1,577 1,607 1,655 1,748 1,805 1,852 1,885 1,936 1,980 2,001
Total Preferred & Common Equity
1,540 1,575 1,605 1,653 1,748 1,805 1,852 1,885 1,936 1,980 2,001
Total Common Equity
1,540 1,575 1,605 1,653 1,748 1,805 1,852 1,885 1,936 1,980 2,001
Common Stock
263 273 286 298 317 338 352 365 387 404 396
Retained Earnings
1,918 1,963 1,991 2,026 2,137 2,180 2,223 2,345 2,398 2,450 2,601
Treasury Stock
-251 -307 - -320 -354 - -382 -466 -489 -517 -629
Accumulated Other Comprehensive Income / (Loss)
-390 -354 -352 -351 -352 -350 -342 -360 -360 -357 -366

Annual Metrics And Ratios for New York Times

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/27/2015 12/25/2016 12/31/2017 12/30/2018 12/29/2019 12/27/2020 12/26/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-0.59% -1.51% 7.09% 4.72% 3.90% -1.58% 16.33% 11.25% 5.10% 6.59% 9.24%
EBITDA Growth
15.62% -17.59% 6.68% 38.26% -1.90% -33.23% 105.66% -11.30% 30.04% 17.26% 15.76%
EBIT Growth
48.55% -25.61% 10.59% 61.88% -7.48% -48.24% 195.69% -24.17% 42.86% 24.35% 19.04%
NOPAT Growth
-13.75% 8.62% -88.02% 1,092.85% 8.56% 3.04% 31.82% -26.67% 42.79% 26.61% 22.27%
Net Income Growth
94.53% -62.08% -71.31% 1,764.27% 9.81% -27.96% 118.15% -20.94% 33.84% 26.24% 17.07%
EPS Growth
90.00% -52.63% -83.33% 2,400.00% 10.67% -27.71% 118.33% -20.61% 34.62% 26.43% 18.08%
Operating Cash Flow Growth
122.48% -41.99% -16.52% 81.19% 20.86% 56.89% -9.68% -44.00% 139.32% 13.84% 42.38%
Free Cash Flow Firm Growth
-32.27% -31.17% -171.79% 226.69% 57.02% 52.87% -982.08% 181.90% -80.95% 13.06% 52.99%
Invested Capital Growth
-11.44% 1.73% 22.65% 13.32% 4.27% -8.95% 436.59% -53.48% -5.36% -3.67% -13.97%
Revenue Q/Q Growth
0.00% -0.32% 2.54% 1.18% 0.39% 31.56% -14.15% 3.28% 0.36% 1.99% 2.75%
EBITDA Q/Q Growth
11.22% -16.37% -19.12% 26.24% 4.88% -32.85% 39.45% 2.63% 11.46% 3.61% 4.38%
EBIT Q/Q Growth
22.67% -24.01% -26.43% 37.85% 2.15% -47.26% 56.82% -0.09% 15.99% 4.80% 2.82%
NOPAT Q/Q Growth
5.46% 8.30% -88.55% 436.76% 13.74% 3.64% 1.35% -0.56% 17.33% 5.80% 2.66%
Net Income Q/Q Growth
39.66% -37.09% -93.32% 907.99% 8.73% -36.30% 36.78% 0.52% 20.41% 4.81% 1.81%
EPS Q/Q Growth
35.71% -30.77% -95.00% 837.50% 9.21% -36.17% 39.36% -0.95% 21.74% 4.12% 2.45%
Operating Cash Flow Q/Q Growth
17.59% -33.70% -47.80% 184.67% 16.97% 8.35% -10.54% 4.23% 24.45% 3.84% 2.18%
Free Cash Flow Firm Q/Q Growth
-47.43% -47.64% -244.63% 176.43% 4.79% 25.59% -857.39% 387.48% 45.26% 6.08% 0.46%
Invested Capital Q/Q Growth
-5.85% 25.72% 27.71% 2.57% 5.13% -2.40% 460.61% 3.72% -1.26% -1.58% -1.13%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
60.88% 59.54% 84.83% 45.65% 45.47% 46.22% 49.90% 47.63% 48.52% 49.36% 50.81%
EBITDA Margin
12.55% 10.50% 10.46% 13.81% 13.04% 8.85% 15.64% 12.47% 15.43% 16.98% 17.99%
Operating Margin
8.65% 7.24% 10.60% 10.90% 9.69% 9.88% 12.92% 8.75% 11.39% 13.58% 15.28%
EBIT Margin
8.65% 6.53% 6.75% 10.43% 9.29% 4.88% 12.41% 8.46% 11.50% 13.42% 14.62%
Profit (Net Income) Margin
3.98% 1.53% 0.41% 7.31% 7.72% 5.65% 10.60% 7.53% 9.59% 11.36% 12.18%
Tax Burden Percent
64.95% 78.07% 6.15% 72.38% 85.11% 87.36% 75.72% 73.69% 76.92% 76.63% 76.23%
Interest Burden Percent
70.84% 30.04% 98.98% 96.81% 97.73% 132.53% 112.79% 120.83% 108.45% 110.52% 109.26%
Effective Tax Rate
35.05% 14.48% 93.47% 27.62% 14.89% 12.64% 24.28% 26.31% 23.08% 23.37% 23.77%
Return on Invested Capital (ROIC)
25.08% 28.75% 3.07% 31.12% 31.14% 32.90% 14.29% 8.49% 19.61% 26.00% 34.83%
ROIC Less NNEP Spread (ROIC-NNEP)
31.17% 43.22% 4.02% 33.05% 32.64% 39.68% -103.53% 22.16% 16.22% 22.95% 33.39%
Return on Net Nonoperating Assets (RNNOA)
-17.00% -25.90% -2.28% -17.98% -18.51% -24.84% 1.04% 2.59% -5.77% -10.08% -17.50%
Return on Equity (ROE)
8.07% 2.85% 0.79% 13.14% 12.63% 8.06% 15.34% 11.07% 13.84% 15.92% 17.34%
Cash Return on Invested Capital (CROIC)
37.21% 27.03% -17.28% 18.63% 26.96% 42.26% -122.87% 81.48% 25.11% 29.74% 49.85%
Operating Return on Assets (OROA)
5.48% 4.41% 5.24% 8.47% 7.85% 3.96% 10.57% 7.66% 10.63% 12.49% 14.15%
Return on Assets (ROA)
2.52% 1.04% 0.32% 5.93% 6.53% 4.59% 9.03% 6.82% 8.87% 10.58% 11.78%
Return on Common Equity (ROCE)
8.05% 2.85% 0.79% 13.13% 12.61% 8.05% 15.31% 11.06% 13.83% 15.92% 17.34%
Return on Equity Simple (ROE_SIMPLE)
7.60% 2.81% 0.76% 12.25% 11.94% 7.61% 14.30% 10.88% 13.20% 15.25% 0.00%
Net Operating Profit after Tax (NOPAT)
89 96 12 138 149 154 203 149 213 269 329
NOPAT Margin
5.62% 6.20% 0.69% 7.89% 8.25% 8.63% 9.78% 6.45% 8.76% 10.40% 11.65%
Net Nonoperating Expense Percent (NNEP)
-6.09% -14.47% -0.95% -1.93% -1.51% -6.79% 117.83% -13.67% 3.39% 3.06% 1.44%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.30% 12.05% 13.96% 16.12%
Cost of Revenue to Revenue
39.12% 40.46% 15.17% 54.35% 54.53% 53.78% 50.10% 52.37% 51.48% 50.64% 49.19%
SG&A Expenses to Revenue
45.20% 46.83% 48.94% 11.27% 11.41% 12.53% 12.05% 12.53% 12.82% 11.91% 11.61%
R&D to Revenue
0.00% 0.00% 0.00% 4.82% 5.87% 7.48% 7.75% 8.85% 9.43% 9.60% 9.36%
Operating Expenses to Revenue
52.23% 52.29% 74.23% 34.75% 35.78% 36.33% 36.98% 38.88% 37.13% 35.78% 35.53%
Earnings before Interest and Taxes (EBIT)
137 102 112 182 168 87 258 195 279 347 413
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
198 163 174 241 236 158 325 288 374 439 508
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.49 2.42 3.17 3.39 4.36 6.26 5.03 3.28 4.51 4.42 5.51
Price to Tangible Book Value (P/TBV)
2.87 2.88 3.77 3.92 4.95 7.19 5.69 6.05 7.49 6.77 8.01
Price to Revenue (P/Rev)
1.30 1.32 1.71 2.02 2.82 4.65 3.73 2.27 3.28 3.29 3.98
Price to Earnings (P/E)
32.56 70.72 662.05 28.06 36.53 82.92 35.15 30.15 34.22 28.97 32.68
Dividend Yield
1.26% 1.25% 0.91% 0.75% 0.62% 0.46% 0.59% 1.07% 0.87% 0.96% 0.97%
Earnings Yield
3.07% 1.41% 0.15% 3.56% 2.74% 1.21% 2.84% 3.32% 2.92% 3.45% 3.06%
Enterprise Value to Invested Capital (EV/IC)
4.71 4.57 5.70 6.29 9.04 16.64 2.78 4.27 6.87 7.49 11.53
Enterprise Value to Revenue (EV/Rev)
0.99 0.99 1.42 1.70 2.44 4.16 3.21 2.06 2.99 2.94 3.57
Enterprise Value to EBITDA (EV/EBITDA)
7.89 9.47 13.55 12.27 18.75 47.03 20.52 16.53 19.35 17.31 19.82
Enterprise Value to EBIT (EV/EBIT)
11.45 15.22 21.02 16.25 26.33 85.20 25.86 24.37 25.96 21.91 24.39
Enterprise Value to NOPAT (EV/NOPAT)
17.64 16.04 204.65 21.48 29.65 48.20 32.82 31.98 34.09 28.25 30.62
Enterprise Value to Operating Cash Flow (EV/OCF)
8.74 14.88 27.23 18.82 23.33 24.91 24.75 31.58 20.09 18.51 17.23
Enterprise Value to Free Cash Flow (EV/FCFF)
11.89 17.07 0.00 35.88 34.24 37.52 0.00 3.33 26.61 24.70 21.40
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.52 0.29 0.28 0.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.29 0.29 0.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.55 -0.60 -0.57 -0.54 -0.57 -0.63 -0.01 0.12 -0.36 -0.44 -0.52
Leverage Ratio
3.20 2.75 2.46 2.21 1.93 1.76 1.70 1.62 1.56 1.51 1.47
Compound Leverage Factor
2.27 0.83 2.44 2.14 1.89 2.33 1.92 1.96 1.69 1.66 1.61
Debt to Total Capital
34.23% 22.63% 21.80% 19.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
14.95% 0.00% 0.00% 19.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
19.28% 22.63% 21.80% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.14% -0.33% 0.01% 0.14% 0.16% 0.20% 0.13% 0.13% 0.00% 0.00% 0.00%
Common Equity to Total Capital
65.63% 77.69% 78.19% 80.29% 99.84% 99.80% 99.87% 99.87% 100.00% 100.00% 100.00%
Debt to EBITDA
2.18 1.51 1.44 1.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
-2.50 -3.10 -2.77 -2.38 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
1.23 1.51 1.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
4.86 2.56 21.68 1.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
-5.59 -5.25 -41.83 -4.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
2.74 2.56 21.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.53 2.86 3.45 3.98 5.73 7.18 6.87 5.66 7.42 8.18 9.79
Noncontrolling Interest Sharing Ratio
0.24% -0.11% -0.20% 0.10% 0.17% 0.18% 0.16% 0.13% 0.06% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.53 2.00 1.80 1.33 1.64 1.72 1.70 1.15 1.28 1.53 1.54
Quick Ratio
1.46 1.87 1.63 1.24 1.48 1.60 1.60 0.99 1.13 1.33 1.40
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
132 91 -65 82 129 198 -1,745 1,429 272 308 471
Operating Cash Flow to CapEx
664.10% 345.16% 102.31% 202.77% 417.90% 864.80% 776.91% 407.69% 1,590.80% 1,407.16% 1,719.89%
Free Cash Flow to Firm to Interest Expense
3.37 2.60 -3.29 4.97 33.87 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
4.59 2.98 4.38 9.48 49.71 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
3.90 2.12 0.10 4.81 37.82 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.63 0.68 0.78 0.81 0.85 0.81 0.85 0.91 0.92 0.93 0.97
Accounts Receivable Turnover
7.52 7.69 8.71 8.56 8.32 8.98 9.96 10.25 10.55 10.51 10.46
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
2.43 2.53 2.69 2.73 2.86 2.92 3.55 4.09 4.54 5.16 5.94
Accounts Payable Turnover
6.49 6.28 2.20 8.00 8.66 8.00 8.31 10.00 10.79 10.89 10.72
Days Sales Outstanding (DSO)
48.52 47.47 41.88 42.62 43.89 40.63 36.64 35.61 34.60 34.72 34.91
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
56.27 58.15 166.09 45.64 42.13 45.61 43.93 36.49 33.84 33.52 34.04
Cash Conversion Cycle (CCC)
-7.75 -10.69 -124.21 -3.01 1.76 -4.98 -7.29 -0.88 0.77 1.20 0.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
332 338 415 470 490 446 2,394 1,114 1,054 1,015 874
Invested Capital Turnover
4.46 4.64 4.43 3.94 3.78 3.81 1.46 1.32 2.24 2.50 2.99
Increase / (Decrease) in Invested Capital
-43 5.77 77 55 20 -44 1,948 -1,280 -60 -39 -142
Enterprise Value (EV)
1,565 1,546 2,362 2,956 4,431 7,421 6,660 4,759 7,244 7,601 10,073
Market Capitalization
2,059 2,056 2,844 3,527 5,113 8,301 7,733 5,244 7,953 8,512 11,241
Book Value per Share
$5.11 $5.26 $5.53 $6.31 $7.06 $7.93 $9.17 $9.66 $10.72 $11.75 $12.57
Tangible Book Value per Share
$4.43 $4.43 $4.65 $5.46 $6.22 $6.90 $8.09 $5.24 $6.46 $7.67 $8.64
Total Capital
1,260 1,091 1,148 1,296 1,174 1,328 1,541 1,600 1,763 1,927 2,041
Total Debt
431 247 250 254 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
243 247 250 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-496 -506 -483 -573 -684 -882 -1,074 -486 -709 -912 -1,168
Capital Expenditures (CapEx)
27 30 85 77 45 34 35 37 23 29 34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-126 -153 -157 -139 -153 -246 -267 -263 -281 -243 -281
Debt-free Net Working Capital (DFNWC)
487 397 334 474 279 349 394 84 170 323 361
Net Working Capital (NWC)
299 397 334 221 279 349 394 84 170 323 361
Net Nonoperating Expense (NNE)
26 73 4.70 10 9.47 53 -17 -25 -20 -25 -15
Net Nonoperating Obligations (NNO)
-496 -506 -483 -573 -684 -882 853 -486 -709 -912 -1,168
Total Depreciation and Amortization (D&A)
62 62 62 59 68 71 67 93 95 92 95
Debt-free, Cash-free Net Working Capital to Revenue
-7.98% -9.82% -9.45% -7.94% -8.45% -13.80% -12.89% -11.39% -11.60% -9.40% -9.94%
Debt-free Net Working Capital to Revenue
30.86% 25.55% 20.06% 27.19% 15.40% 19.57% 18.97% 3.66% 7.01% 12.48% 12.79%
Net Working Capital to Revenue
18.93% 25.55% 20.06% 12.65% 15.40% 19.57% 18.97% 3.66% 7.01% 12.48% 12.79%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.38 $0.18 $0.03 $0.76 $0.84 $0.60 $1.31 $1.04 $1.41 $1.79 $2.11
Adjusted Weighted Average Basic Shares Outstanding
164.39M 161.13M 161.93M 164.85M 166.04M 166.97M 167.93M 166.87M 164.72M 164.43M 163.16M
Adjusted Diluted Earnings per Share
$0.38 $0.18 $0.03 $0.75 $0.83 $0.60 $1.31 $1.04 $1.40 $1.77 $2.09
Adjusted Weighted Average Diluted Shares Outstanding
166.42M 162.82M 164.26M 166.94M 167.55M 168.04M 168.53M 167.14M 165.66M 165.80M 164.94M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
160.21M 161.20M 164.82M 165.92M 166.40M 167.44M 167.53M 164.47M 164.10M 163.30M 161.24M
Normalized Net Operating Profit after Tax (NOPAT)
89 110 124 138 153 154 206 177 224 277 341
Normalized NOPAT Margin
5.62% 7.10% 7.42% 7.89% 8.43% 8.63% 9.92% 7.69% 9.24% 10.72% 12.08%
Pre Tax Income Margin
6.13% 1.96% 6.68% 10.10% 9.08% 6.47% 14.00% 10.22% 12.47% 14.83% 15.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.50 2.92 5.68 10.98 44.05 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
2.27 2.77 0.58 8.31 39.12 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
2.81 2.05 1.40 6.30 32.16 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
1.58 1.90 -3.70 3.63 27.22 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
42.33% 108.66% 380.34% 20.73% 22.58% 38.12% 20.61% 32.66% 30.00% 28.20% 32.08%
Augmented Payout Ratio
152.59% 174.48% 380.34% 20.73% 22.58% 38.12% 20.61% 93.07% 49.14% 57.14% 80.15%

Quarterly Metrics And Ratios for New York Times

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 161,238,685.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 161,238,685.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.55
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.25% 1.30% 5.93% 5.80% 6.99% 7.46% 7.05% 9.72% 9.47% 10.42% 12.00%
EBITDA Growth
19.61% 33.41% 35.21% 25.18% 12.16% 9.95% 10.70% 24.20% 23.20% 5.23% 42.03%
EBIT Growth
30.44% 42.15% 65.36% 38.84% 17.78% 12.25% 14.23% 30.01% 32.34% 7.79% 61.19%
NOPAT Growth
32.53% 44.72% 78.94% 40.29% 18.84% 14.62% 29.44% 32.43% 36.89% 7.37% 78.42%
Net Income Growth
46.42% 55.74% 81.07% 40.72% 19.64% 12.23% 22.60% 26.56% 27.29% 4.94% 77.44%
EPS Growth
45.45% 59.52% 84.62% 42.86% 21.88% 10.45% 25.00% 25.00% 28.21% 6.76% 80.00%
Operating Cash Flow Growth
51.46% 107.91% 4.63% 16.19% 20.31% 11.12% 86.68% 41.64% 65.42% 8.21% -6.92%
Free Cash Flow Firm Growth
109.01% -88.05% 221.29% 132.89% 70.46% -3.80% 64.43% 132.79% 142.76% 71.98% 35.87%
Invested Capital Growth
-0.58% -5.36% -3.69% -1.44% -3.35% -3.67% -7.46% -8.96% -14.37% -13.97% -8.98%
Revenue Q/Q Growth
1.27% 13.01% -12.16% 5.23% 2.41% 13.50% -12.48% 7.86% 2.18% 14.48% -11.23%
EBITDA Q/Q Growth
8.79% 74.82% -54.33% 44.12% -2.52% 71.37% -54.02% 61.70% -3.31% 46.38% -37.94%
EBIT Q/Q Growth
13.80% 101.89% -63.56% 65.84% -3.46% 92.40% -62.92% 88.74% -1.73% 56.71% -44.54%
NOPAT Q/Q Growth
14.31% 108.84% -65.50% 70.32% -3.17% 101.43% -61.04% 74.26% 0.09% 57.99% -35.25%
Net Income Q/Q Growth
15.12% 105.62% -63.34% 62.16% -2.13% 92.89% -59.95% 67.39% -1.56% 59.02% -32.28%
EPS Q/Q Growth
14.29% 109.38% -64.18% 66.67% -2.50% 89.74% -59.46% 66.67% 0.00% 58.00% -31.65%
Operating Cash Flow Q/Q Growth
51.07% 30.87% -61.12% 51.15% 56.43% 20.87% -34.68% 14.68% 82.69% -20.93% -43.81%
Free Cash Flow Firm Q/Q Growth
69.29% 193.65% -53.05% -0.22% 23.92% 65.72% -19.75% 41.26% 29.22% 17.40% -36.60%
Invested Capital Q/Q Growth
-2.68% -1.26% 0.73% 1.82% -4.56% -1.58% -3.23% 0.17% -10.23% -1.13% 2.38%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
48.00% 52.51% 46.66% 48.36% 48.16% 53.48% 47.38% 50.61% 50.19% 54.23% 49.04%
EBITDA Margin
14.69% 22.73% 11.82% 16.18% 15.40% 23.26% 12.22% 18.32% 17.34% 22.17% 15.49%
Operating Margin
10.62% 19.08% 8.13% 12.70% 11.99% 20.18% 9.22% 15.54% 14.95% 20.14% 12.72%
EBIT Margin
10.74% 19.18% 7.96% 12.54% 11.82% 20.04% 8.49% 14.86% 14.29% 19.56% 12.22%
Profit (Net Income) Margin
8.96% 16.30% 6.80% 10.48% 10.02% 17.03% 7.79% 12.09% 11.65% 16.18% 12.34%
Tax Burden Percent
76.61% 78.82% 72.62% 75.26% 75.42% 79.49% 77.46% 74.28% 75.60% 77.46% 89.43%
Interest Burden Percent
108.93% 107.83% 117.74% 111.09% 112.38% 106.89% 118.47% 109.57% 107.84% 106.81% 112.96%
Effective Tax Rate
23.39% 21.18% 27.38% 24.74% 24.58% 20.51% 22.54% 25.72% 24.40% 22.54% 10.57%
Return on Invested Capital (ROIC)
18.38% 33.67% 13.43% 21.89% 21.84% 40.09% 18.36% 30.05% 32.45% 46.66% 35.18%
ROIC Less NNEP Spread (ROIC-NNEP)
17.45% 32.24% 12.51% 20.96% 20.95% 39.21% 17.84% 29.59% 32.20% 46.21% 34.49%
Return on Net Nonoperating Assets (RNNOA)
-5.76% -11.46% -4.37% -7.58% -8.41% -17.22% -7.80% -13.26% -16.11% -24.22% -17.83%
Return on Equity (ROE)
12.61% 22.21% 9.06% 14.31% 13.43% 22.87% 10.56% 16.79% 16.35% 22.44% 17.34%
Cash Return on Invested Capital (CROIC)
17.50% 25.11% 24.83% 23.96% 27.64% 29.74% 35.09% 38.34% 48.94% 49.85% 48.30%
Operating Return on Assets (OROA)
10.26% 17.73% 7.68% 12.14% 11.29% 18.65% 8.33% 14.58% 13.91% 18.93% 12.67%
Return on Assets (ROA)
8.56% 15.07% 6.57% 10.15% 9.57% 15.85% 7.64% 11.87% 11.34% 15.66% 12.80%
Return on Common Equity (ROCE)
12.60% 22.19% 9.05% 14.30% 13.42% 22.87% 10.56% 16.79% 16.35% 22.44% 17.34%
Return on Equity Simple (ROE_SIMPLE)
11.69% 0.00% 14.35% 14.95% 15.14% 0.00% 16.07% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
49 102 35 60 58 117 45 79 79 125 81
NOPAT Margin
8.14% 15.04% 5.91% 9.56% 9.04% 16.04% 7.14% 11.54% 11.30% 15.60% 11.38%
Net Nonoperating Expense Percent (NNEP)
0.93% 1.43% 0.92% 0.94% 0.89% 0.88% 0.52% 0.45% 0.25% 0.45% 0.69%
Return On Investment Capital (ROIC_SIMPLE)
- 5.77% - - - 6.05% 2.41% 4.09% 4.00% 6.13% 4.05%
Cost of Revenue to Revenue
52.00% 47.49% 53.34% 51.64% 51.84% 46.52% 52.62% 49.39% 49.81% 45.77% 50.96%
SG&A Expenses to Revenue
13.68% 11.22% 13.27% 12.30% 11.90% 10.46% 12.57% 12.04% 10.94% 11.09% 12.14%
R&D to Revenue
9.60% 8.62% 10.64% 9.95% 9.53% 8.50% 10.46% 9.32% 9.56% 8.34% 9.86%
Operating Expenses to Revenue
37.38% 33.43% 38.52% 35.66% 36.18% 33.30% 38.16% 35.07% 35.24% 34.09% 36.32%
Earnings before Interest and Taxes (EBIT)
64 130 47 78 76 146 54 102 100 157 87
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
88 154 70 101 99 169 78 126 121 178 110
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.04 4.51 4.04 4.65 4.92 4.42 4.28 4.70 4.70 5.51 6.73
Price to Tangible Book Value (P/TBV)
7.06 7.49 6.70 7.50 7.79 6.77 6.62 7.09 6.98 8.01 9.82
Price to Revenue (P/Rev)
2.77 3.28 2.87 3.37 3.60 3.29 3.07 3.38 3.39 3.98 4.64
Price to Earnings (P/E)
34.58 34.22 28.21 31.15 32.58 28.97 26.64 28.40 27.57 32.68 35.21
Dividend Yield
0.98% 0.87% 1.02% 0.90% 0.86% 0.96% 1.05% 1.02% 1.08% 0.97% 0.86%
Earnings Yield
2.89% 2.92% 3.54% 3.21% 3.07% 3.45% 3.75% 3.52% 3.63% 3.06% 2.84%
Enterprise Value to Invested Capital (EV/IC)
5.71 6.87 6.01 7.09 8.05 7.49 7.30 8.28 9.30 11.53 13.82
Enterprise Value to Revenue (EV/Rev)
2.52 2.99 2.59 3.08 3.27 2.94 2.73 3.03 2.99 3.57 4.26
Enterprise Value to EBITDA (EV/EBITDA)
18.16 19.35 16.25 18.57 19.59 17.31 16.06 17.30 16.88 19.82 22.85
Enterprise Value to EBIT (EV/EBIT)
25.35 25.96 21.43 24.00 25.07 21.91 20.27 21.60 20.46 24.39 27.70
Enterprise Value to NOPAT (EV/NOPAT)
33.67 34.09 27.99 31.29 32.64 28.25 25.65 27.25 25.65 30.62 33.85
Enterprise Value to Operating Cash Flow (EV/OCF)
21.05 20.09 17.58 20.50 21.00 18.51 15.70 16.63 14.37 17.23 21.39
Enterprise Value to Free Cash Flow (EV/FCFF)
32.55 26.61 23.75 29.39 28.61 24.70 19.98 20.58 17.54 21.40 27.26
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.33 -0.36 -0.35 -0.36 -0.40 -0.44 -0.44 -0.45 -0.50 -0.52 -0.52
Leverage Ratio
1.58 1.56 1.53 1.51 1.51 1.51 1.47 1.46 1.47 1.47 1.44
Compound Leverage Factor
1.72 1.68 1.80 1.68 1.70 1.61 1.75 1.60 1.59 1.57 1.63
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
99.88% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
6.70 7.23 7.05 8.05 8.24 7.95 8.03 8.67 8.55 9.51 11.95
Noncontrolling Interest Sharing Ratio
0.13% 0.06% 0.06% 0.06% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.19 1.28 1.25 1.32 1.35 1.53 1.44 1.48 1.52 1.54 1.60
Quick Ratio
1.02 1.13 1.02 1.09 1.16 1.33 1.29 1.30 1.33 1.40 1.44
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
55 161 76 76 94 155 125 176 227 267 169
Operating Cash Flow to CapEx
1,815.17% 2,227.05% 826.26% 1,051.52% 1,777.45% 1,882.55% 1,072.73% 1,099.44% 2,635.29% 2,512.70% 860.17%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.96 0.92 0.97 0.97 0.96 0.93 0.98 0.98 0.97 0.97 1.04
Accounts Receivable Turnover
14.76 10.55 14.31 14.66 14.37 10.51 14.20 13.70 13.99 10.46 13.58
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
4.46 4.54 4.67 4.82 4.98 5.16 5.31 5.48 5.69 5.94 6.16
Accounts Payable Turnover
10.53 10.79 10.38 10.98 10.06 10.89 10.96 11.14 10.15 10.72 10.93
Days Sales Outstanding (DSO)
24.73 34.60 25.50 24.90 25.41 34.72 25.71 26.63 26.09 34.91 26.88
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
34.66 33.84 35.17 33.25 36.27 33.52 33.31 32.75 35.95 34.04 33.39
Cash Conversion Cycle (CCC)
-9.93 0.77 -9.68 -8.35 -10.86 1.20 -7.61 -6.12 -9.86 0.87 -6.51
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,067 1,054 1,062 1,081 1,032 1,015 983 984 883 874 894
Invested Capital Turnover
2.26 2.24 2.27 2.29 2.42 2.50 2.57 2.60 2.87 2.99 3.09
Increase / (Decrease) in Invested Capital
-6.26 -60 -41 -16 -36 -39 -79 -97 -148 -142 -88
Enterprise Value (EV)
6,099 7,244 6,380 7,669 8,301 7,601 7,168 8,147 8,218 10,073 12,356
Market Capitalization
6,685 7,953 7,067 8,393 9,121 8,512 8,070 9,098 9,315 11,241 13,463
Book Value per Share
$10.06 $10.72 $10.62 $10.99 $11.28 $11.75 $11.54 $11.87 $12.16 $12.57 $12.41
Tangible Book Value per Share
$5.76 $6.46 $6.41 $6.81 $7.13 $7.67 $7.46 $7.87 $8.20 $8.64 $8.50
Total Capital
1,655 1,763 1,748 1,805 1,852 1,927 1,885 1,936 1,980 2,041 2,001
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-588 -709 -686 -724 -820 -912 -902 -952 -1,097 -1,168 -1,107
Capital Expenditures (CapEx)
5.75 6.13 6.42 7.63 7.06 8.06 9.24 10 7.88 6.53 11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-294 -281 -243 -238 -288 -243 -275 -263 -295 -281 -245
Debt-free Net Working Capital (DFNWC)
104 170 136 173 205 323 247 277 323 361 349
Net Working Capital (NWC)
104 170 136 173 205 323 247 277 323 361 349
Net Nonoperating Expense (NNE)
-4.92 -8.54 -5.33 -5.77 -6.27 -7.16 -4.13 -3.80 -2.43 -4.68 -6.89
Net Nonoperating Obligations (NNO)
-588 -709 -686 -724 -820 -912 -902 -952 -1,097 -1,168 -1,107
Total Depreciation and Amortization (D&A)
24 24 23 23 23 23 24 24 21 21 23
Debt-free, Cash-free Net Working Capital to Revenue
-12.17% -11.60% -9.86% -9.56% -11.34% -9.40% -10.48% -9.79% -10.71% -9.94% -8.45%
Debt-free Net Working Capital to Revenue
4.31% 7.01% 5.55% 6.94% 8.10% 12.48% 9.39% 10.30% 11.74% 12.79% 12.04%
Net Working Capital to Revenue
4.31% 7.01% 5.55% 6.94% 8.10% 12.48% 9.39% 10.30% 11.74% 12.79% 12.04%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.33 $0.66 $0.25 $0.40 $0.39 $0.75 $0.30 $0.51 $0.50 $0.80 $0.54
Adjusted Weighted Average Basic Shares Outstanding
164.57M 164.72M 164.63M 164.54M 164.42M 164.43M 163.78M 163.33M 163.02M 163.16M 162.04M
Adjusted Diluted Earnings per Share
$0.32 $0.67 $0.24 $0.40 $0.39 $0.74 $0.30 $0.50 $0.50 $0.79 $0.54
Adjusted Weighted Average Diluted Shares Outstanding
165.41M 165.66M 165.63M 165.51M 165.85M 165.80M 164.91M 164.35M 164.40M 164.94M 163.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
164.41M 164.10M 164.31M 164.23M 163.95M 163.30M 163.05M 162.82M 162.35M 161.24M 161.86M
Normalized Net Operating Profit after Tax (NOPAT)
51 102 36 61 61 119 49 82 81 128 85
Normalized NOPAT Margin
8.46% 15.04% 6.03% 9.80% 9.58% 16.39% 7.68% 11.92% 11.56% 15.89% 11.91%
Pre Tax Income Margin
11.70% 20.68% 9.37% 13.93% 13.28% 21.42% 10.06% 16.28% 15.41% 20.89% 13.80%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
34.29% 30.00% 29.25% 28.41% 28.52% 28.20% 28.49% 29.50% 30.32% 32.08% 31.04%
Augmented Payout Ratio
69.90% 49.14% 47.70% 44.34% 50.39% 57.14% 65.30% 68.70% 70.15% 80.15% 73.60%

Financials Breakdown Chart

Key Financial Trends

New York Times (NYSE: NYT) has shown a pattern of revenue growth with solid cash generation over the last four years. In Q4 2025, NYT posted a revenue of about $802.3 million and net income of roughly $129.8 million, continuing a multi-year trend of improving profitability and strong operating cash flow. The balance sheet remains liquidity-friendly, with meaningful cash and short-term investments and a manageable liability load relative to equity. The quarterly data also indicates modest share repurchases and a steady dividend, which can be a positive signal for investors focusing on cash returns.

  • Revenue growth: Q4 2025 operating revenue and total revenue were 802.314 million, up from 726.629 million in Q4 2024, a roughly 10.4% year-over-year increase.
  • Net income growth: Net income from continuing operations rose to 129.838 million in Q4 2025 from 123.725 million in Q4 2024 (+4.9%).
  • Gross margin stability/improvement: Gross margin improved to about 54.3% in Q4 2025 (435.092 million gross profit on 802.314 million revenue) versus about 53.5% in Q4 2024.
  • Operating cash flow strength: Net cash from continuing operating activities was 160.451 million in Q4 2025 vs 151.696 million in Q4 2024, a positive growth trend.
  • Earnings per share: Diluted EPS rose to 0.79 in Q4 2025 from 0.75 in Q4 2024 (basic EPS 0.80 vs 0.75).
  • Shareholder returns: Cash dividends per share remained at 0.18, and the company executed a modest share repurchase (55.46 million) in Q4 2025, potentially supporting EPS.
  • Liquidity and balance sheet position: Cash and short-term investments total about 617.4 million; total current assets around 938.3 million; current liabilities about 615.5 million, implying a roughly 1.5x current ratio.
  • Investing and financing mix: Investing activities used about 72.2 million in net cash and financing activities were a net outflow of about 85.4 million, reflecting ongoing reinvestment and capital returns.
05/19/26 11:43 PM ETAI Generated. May Contain Errors.

New York Times Financials - Frequently Asked Questions

According to the most recent income statement we have on file, New York Times' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

New York Times' net income appears to be on an upward trend, with a most recent value of $343.98 million in 2025, rising from $62.84 million in 2015. The previous period was $293.83 million in 2024. See where experts think New York Times is headed by visiting New York Times' forecast page.

New York Times' total operating income in 2025 was $431.56 million, based on the following breakdown:
  • Total Gross Profit: $1.44 billion
  • Total Operating Expenses: $1.00 billion

Over the last 10 years, New York Times' total revenue changed from $1.58 billion in 2015 to $2.82 billion in 2025, a change of 78.9%.

New York Times' total liabilities were at $955.73 million at the end of 2025, a 4.5% increase from 2024, and a 39.9% decrease since 2015.

In the past 10 years, New York Times' cash and equivalents has ranged from $100.69 million in 2016 to $319.97 million in 2021, and is currently $255.45 million as of their latest financial filing in 2025.

Over the last 10 years, New York Times' book value per share changed from 5.11 in 2015 to 12.57 in 2025, a change of 146.2%.



Financial statements for NYSE:NYT last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners